Steven W. Lefkowitz - 16 Nov 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Steven W. Lefkowitz
Issuer symbol
CRMD
Transactions as of
16 Nov 2023
Net transactions value
+$33,750
Form type
4
Filing time
17 Nov 2023, 16:50:49 UTC
Previous filing
18 Jan 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $33,750 +15,000 +25% $2.25 75,498 16 Nov 2023 Direct
holding CRMD Common Stock 30,152 16 Nov 2023 Wade Capital Corporation Money Purchase Plan F1
holding CRMD Common Stock 2,000 16 Nov 2023 Reporting Person's Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -15,000 -100% $0.000000* 0 16 Nov 2023 Common Stock 15,000 $2.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
F2 These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on June 25, 2017. These stock options are fully vested.